Literature DB >> 18267114

Alternative splicing produces a constitutively active form of human SREBP-1.

Nagakatsu Harada1, Haruka Yonemoto, Masaki Yoshida, Hironori Yamamoto, Yunjie Yin, Aiko Miyamoto, Atsushi Hattori, Qishisan Wu, Tadahiko Nakagawa, Masayuki Nakano, Kiyoshi Teshigawara, Kazuaki Mawatari, Toshio Hosaka, Akira Takahashi, Yutaka Nakaya.   

Abstract

We identified a novel alternative splicing event that constitutively produces a truncated active form of human sterol regulatory element-binding protein 1 (SREBP-1). A cDNA of this splicing variant (named SREBP-1Delta) contains a translational stop codon-encoding exon sequence between exons 7 and 8. It produces SREBP-1aDelta (470 a.a.) and SREBP-1cDelta (446 a.a.) proteins that lack transmembrane and C-terminal regulatory sequences necessary for localization of SREBP-1 to the endoplasmic reticulum. A luciferase reporter assay showed that SREBP-1aDelta and SREBP-1cDelta transactivated lipogenic gene promoters to the same extent as that induced by N-terminal active fragments of SREBP-1a and SREBP-1c, respectively. SREBP-1Delta mRNA is expressed in human cell lines as well as adipose and liver tissues. Expression levels ranged from 5% to 16% of total SREBP-1 expression. The ratio of SREBP-1Delta expression to total SREBP-1 expression in HepG2 cells was not affected by either insulin or high glucose treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18267114     DOI: 10.1016/j.bbrc.2008.02.004

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  C-terminal region of GADD34 regulates eIF2α dephosphorylation and cell proliferation in CHO-K1 cells.

Authors:  Ryo Otsuka; Nagakatsu Harada; Shouhei Aoki; Kanna Shirai; Kazuchika Nishitsuji; Ayane Nozaki; Adzumi Hatakeyama; Masayuki Shono; Noriko Mizusawa; Katsuhiko Yoshimoto; Yutaka Nakaya; Hiroshi Kitahata; Hiroshi Sakaue
Journal:  Cell Stress Chaperones       Date:  2015-08-30       Impact factor: 3.667

2.  Genetic variations in SREBP-1 and LXRα are not directly associated to PCOS but contribute to the physiological specifics of the syndrome.

Authors:  Birgit Knebel; Onno E Janssen; Susanne Hahn; Sylvia Jacob; Ulrike Nitzgen; Jutta Haas; Dirk Muller-Wieland; Jorg Kotzka
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

Review 3.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

4.  The Administration of Chitosan-Tripolyphosphate-DNA Nanoparticles to Express Exogenous SREBP1a Enhances Conversion of Dietary Carbohydrates into Lipids in the Liver of Sparus aurata.

Authors:  Jonás I Silva-Marrero; Juliana Villasante; Ania Rashidpour; Mariana Palma; Anna Fàbregas; María Pilar Almajano; Ivan Viegas; John G Jones; Montserrat Miñarro; Josep R Ticó; Isabel V Baanante; Isidoro Metón
Journal:  Biomolecules       Date:  2019-07-24

5.  Preventing phosphorylation of sterol regulatory element-binding protein 1a by MAP-kinases protects mice from fatty liver and visceral obesity.

Authors:  Jorg Kotzka; Birgit Knebel; Jutta Haas; Lorena Kremer; Sylvia Jacob; Sonja Hartwig; Ulrike Nitzgen; Dirk Muller-Wieland
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

Review 6.  Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer.

Authors:  Qiushi Zhao; Xingyu Lin; Guan Wang
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

7.  Perilipin-mediated lipid droplet formation in adipocytes promotes sterol regulatory element-binding protein-1 processing and triacylglyceride accumulation.

Authors:  Yu Takahashi; Akihiro Shinoda; Norihiko Furuya; Eri Harada; Naoto Arimura; Ikuyo Ichi; Yoko Fujiwara; Jun Inoue; Ryuichiro Sato
Journal:  PLoS One       Date:  2013-05-29       Impact factor: 3.240

8.  Identification of novel genes and pathways regulating SREBP transcriptional activity.

Authors:  Sandipan Chatterjee; Joseph D Szustakowski; Nirmala R Nanguneri; Craig Mickanin; Mark A Labow; Axel Nohturfft; Kumlesh K Dev; Rajeev Sivasankaran
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.